2025. SAFETY, EFFICACY AND TOLERABILITY OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITORS (ARNI) IN PATIENTS WITH CHRONIC HEART FAILURE. The Research of Medical Science Review. 3, 1 (Jan. 2025), 522–531.